Reply: Low-Dose Tocilizumab With High-Dose Corticosteroids in Patients Hospitalized for COVID-19 Hypoxic Respiratory Failure Improves Mortality Without Increased Infection Risk
Ann Pharmacother. 2021 Jul 30:10600280211036047. doi: 10.1177/10600280211036047. Online ahead of print.NO ABSTRACTPMID:34330173 | DOI:10.1177/10600280211036047
Source: The Annals of Pharmacotherapy - Category: Drugs & Pharmacology Authors: Xian Jie Cindy Chen Diana Altshuler Peter Spiegler Shari B Brosnahan Source Type: research
More News: Actemra | Corticosteroid Therapy | COVID-19 | Drugs & Pharmacology | Respiratory Medicine